Estrogen deficiency and bone loss: an inflammatory tale
Reads0
Chats0
TLDR
The current understanding of the process of estrogen deficiency-mediated bone destruction is presented and some recent findings and hypotheses to explain estrogen action in bone are explored.Abstract:
Estrogen plays a fundamental role in skeletal growth and bone homeostasis in both men and women. Although remarkable progress has been made in our understanding of how estrogen deficiency causes bone loss, the mechanisms involved have proven to be complex and multifaceted. Although estrogen is established to have direct effects on bone cells, recent animal studies have identified additional unexpected regulatory effects of estrogen centered at the level of the adaptive immune response. Furthermore, a potential role for reactive oxygen species has now been identified in both humans and animals. One major challenge is the integration of a multitude of redundant pathways and cytokines, each apparently capable of playing a relevant role, into a comprehensive model of postmenopausal osteoporosis. This Review presents our current understanding of the process of estrogen deficiency-mediated bone destruction and explores some recent findings and hypotheses to explain estrogen action in bone. Due to the inherent difficulties associated with human investigation, many of the lessons learned have been in animal models. Consequently, many of these principles await further validation in humans.read more
Citations
More filters
Journal ArticleDOI
The complex role of estrogens in inflammation
TL;DR: This review reinforces the concept that estrogens have antiinflammatory but also proinflammatory roles depending on above-mentioned criteria and explains that a uniform concept as to the action of estrogens cannot be found for all inflammatory diseases due to the enormous variable responses of immune and repair systems.
Journal ArticleDOI
Developmental basis of sexually dimorphic digit ratios
Zhengui Zheng,Martin J. Cohn +1 more
TL;DR: The studies identify previously undescribed molecular dimorphisms between male and female limb buds and provide experimental evidence that the digit ratio is a lifelong signature of prenatal hormonal exposure and suggest that the 2D:4D ratio can serve as an indicator of disrupted endocrine signaling during early development, which may aid in the identification of fetal origins of adult diseases.
Journal ArticleDOI
Estrogens and Androgens in Skeletal Physiology and Pathophysiology.
Maria Almeida,Michaël R. Laurent,Vanessa Dubois,Frank Claessens,Charles A. O'Brien,Roger Bouillon,Dirk Vanderschueren,Stavros C. Manolagas +7 more
TL;DR: A comprehensive review of the molecular and cellular mechanisms of action of estrogens and androgens on bone, their influences on skeletal homeostasis during growth and adulthood, the pathogenetic mechanisms of the adverse effects of their deficiency on the female and male skeleton, as well as the role of natural and synthetic estrogenic or androgenic compounds in the pharmacotherapy of osteoporosis is provided.
Journal ArticleDOI
Efficacy of bazedoxifene in reducing new vertebral fracture risk in postmenopausal women with osteoporosis: results from a 3-year, randomized, placebo-, and active-controlled clinical trial.
Stuart L. Silverman,Claus Christiansen,Harry K. Genant,Slobodan Vukicevic,J.R. Zanchetta,Tobie de Villiers,Ginger D. Constantine,Arkadi Chines +7 more
TL;DR: Bazedoxifene significantly reduced the risk of new vertebral fracture in postmenopausal women with osteoporosis and decreased the risk in subjects at higher fracture risk and in a posthoc analysis of a subgroup of women atHigher fracture risk.
Journal ArticleDOI
Inhibition of osteoblastic bone formation by nuclear factor-kappaB.
Jia Chang,Zhuo Wang,Eric C Tang,Zhipeng Fan,Laurie K. McCauley,Renny T. Franceschi,Kun-Liang Guan,Paul H. Krebsbach,Cun-Yu Wang +8 more
TL;DR: It is shown that the time- and stage-specific inhibition of endogenous inhibitor of κB kinase–nuclear factor-κB in differentiated osteoblasts substantially increases trabecular bone mass and bone mineral density without affecting osteoclast activities in young mice, suggesting that targeting IKK–NF-κBs may help to promote bone formation in the treatment of osteoporosis and other bone diseases.
References
More filters
Journal ArticleDOI
Cloning of a novel receptor expressed in rat prostate and ovary.
TL;DR: It is concluded that clone 29 cDNA encodes a novel rat ER, which is suggested be named rat ERbeta to distinguish it from the previously cloned ER (ERalpha) from rat uterus.
Journal ArticleDOI
Bone Resorption by Osteoclasts
TL;DR: Osteopetrotic mutants have provided a wealth of information about the genes that regulate the differentiation of osteoclasts and their capacity to resorb bone.
Journal ArticleDOI
Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis.
TL;DR: The role and the molecular mechanism of action of regulatory molecules, such as cytokines and hormones, in osteoclast and osteoblast birth and apoptosis are reviewed to review the evidence for the contribution of changes in bone cell birth or death to the pathogenesis of the most common forms of osteoporosis.
Journal ArticleDOI
Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand
Young-Yun Kong,Ulrich Feige,Iidiko Sarosi,Brad Bolon,Anna Tafuri,Sean Morony,Casey Capparelli,Ji Li,Robin Elliott,Susan McCabe,Tom Wong,G Campagnuolo,Erika Moran,Earl R. Bogoch,Gwyneth Van,Linh T. Nguyen,Pamela S. Ohashi,David L. Lacey,Eleanor N. Fish,William J. Boyle,Josef M. Penninger,Josef M. Penninger +21 more
TL;DR: The results show that both systemic and local T-cell activation can lead to OPGL production and subsequent bone loss, and they provide a novel paradigm for T cells as regulators of bone physiology.
Journal ArticleDOI
Sex steroids and the construction and conservation of the adult skeleton.
TL;DR: A new unitary model for the pathophysiology of involutional osteoporosis is reviewed and extended that identifies estrogen (E) as the key hormone for maintaining bone mass and E deficiency as the major cause of age-related bone loss in both sexes.